(DBXX) Xtrackers - FTSE 100 Income - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0292097234 • UK Large-Cap Equity
DBXX: Equities, UK, Dividend, Stocks, Shares, Income
The Xtrackers - FTSE 100 Income UCITS ETF (DBXX) is a Germany-domiciled exchange-traded fund listed on XETRA. It tracks the Morningstar UK All Cap TME NR GBP Index, focusing on UK large-cap equities with an emphasis on income generation. The fund provides exposure to high-dividend-paying stocks within the UK market, leveraging a replication strategy to closely align with its underlying index.
From a technical perspective, DBXX is currently trading at 10.13 EUR, slightly below its 20-day simple moving average (SMA) of 10.17. The 50-day SMA stands at 9.89, while the 200-day SMA is at 9.62, indicating a bearish trend over the medium to long term. The Average True Range (ATR) of 0.08 reflects low volatility, suggesting stable price movements. The average 20-day trading volume is 9,156 shares, indicating moderate liquidity.
As of the latest data, the funds assets under management (AUM) total 63.21 million EUR, reflecting its position as a mid-sized ETF in the UK large-cap equity category. The funds income-focused strategy appeals to investors seeking regular dividends alongside exposure to the UK equity market.
3-Month Forecast: Based on the current technical and fundamental data, DBXX is expected to trade sideways to slightly lower in the next three months. The SMA crossover pattern suggests bearish momentum, with the 20-day SMA below the 50-day SMA. Support levels are likely to be tested near the 200-day SMA of 9.62. The low ATR indicates that price fluctuations will remain muted, with potential downside limited by the funds income generation strategy. Investors should monitor UK macroeconomic indicators and corporate earnings reports for potential catalysts.
Additional Sources for DBXX ETF
DBXX ETF Overview
Market Cap in USD | 68m |
Category | UK Large-Cap Equity |
TER | 0.09% |
IPO / Inception | 2007-06-05 |
DBXX ETF Ratings
Growth 5y | 72.4% |
Fundamental | - |
Dividend | 34.8% |
Rel. Strength Industry | -10.6 |
Analysts | - |
Fair Price Momentum | 10.29 EUR |
Fair Price DCF | - |
DBXX Dividends
Dividend Yield 12m | 3.28% |
Yield on Cost 5y | 5.23% |
Annual Growth 5y | -0.74% |
Payout Consistency | 82.1% |
DBXX Growth Ratios
Growth Correlation 3m | 82.5% |
Growth Correlation 12m | 76.9% |
Growth Correlation 5y | 94% |
CAGR 5y | 10.18% |
CAGR/Max DD 5y | 0.47 |
Sharpe Ratio 12m | 1.20 |
Alpha | 5.55 |
Beta | 0.43 |
Volatility | 17.78% |
Current Volume | 6.7k |
Average Volume 20d | 2.7k |
As of March 09, 2025, the stock is trading at EUR 10.04 with a total of 6,705 shares traded.
Over the past week, the price has changed by -2.79%, over one month by -0.27%, over three months by +2.75% and over the past year by +14.53%.
Yes. Based on ValueRay Analyses, Xtrackers - FTSE 100 Income (XETRA:DBXX) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 72.42 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBXX as of March 2025 is 10.29. This means that DBXX is currently overvalued and has a potential downside of 2.49%.
Xtrackers - FTSE 100 Income has no consensus analysts rating.
According to ValueRays Forecast Model, DBXX Xtrackers - FTSE 100 Income will be worth about 11.5 in March 2026. The stock is currently trading at 10.04. This means that the stock has a potential upside of +14.14%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 11.5 | 14.1% |